Pembrolizumab vs Sodium Iodide I 131
Pembrolizumab vs Sodium Iodide I 131: Overview
This comparison examines the pharmacological differences between Pembrolizumab and Sodium Iodide I 131.
Mechanism of Action
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Pharmacokinetics
Half-life: Pembrolizumab — 26 days.
Chemical Properties
Type: Pembrolizumab — Antibody; Sodium Iodide I 131 — Small molecule.